Table 5

Chemotherapy Associated With Bradycardia

Chemotherapy AgentsIncidence (%)Frequency of Use
Angiogenesis inhibitor
 Thalidomide (Thalomid) (138,140,156–159)0.12–55+
Antimicrotubule agent
 Paclitaxel (Taxol) (10,90,91,154,155)<0.1–31+++

For an explanation of the + symbols, please see Table 1.

  • The incidence of bradycardia varies widely in the literature for these agents due to the differences in study design, definition of bradycardia, and numbers of patients. Medication manufacturers and locations as in Tables 2 and 4.